Authors
Latest:
The Long-term Social Value of Granulocyte Colony-Stimulating FactorsAlthough currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.
Latest:
Electronic Health Record Problem Lists: Accurate Enough for Risk Adjustment?Electronic health record (EHR)-based comorbidity assessment had low sensitivity for identifying major comorbidities and poorly predicted survival. EHR-based comorbidity data require validation prior to application to risk adjustment.
Latest:
"No-Shows": Who Fails to Follow Up With Initial Behavioral Health Treatment?Patients who obtained authorization but did not get initial mental health treatment needed treatment as much as or more than patients who presented for care.
Latest:
Current Value-Based Care Models Need Greater Emphasis on Specialty CareThis article provides an overview of the impact of specialty care and the opportunity for it to leapfrog primary care as a lead focus for accountable care.
Latest:
A Web-Based Clinical Decision Support System for Depression Care ManagementThis article describes the development and capabilities of a Webbased decision support system for care managers working in the context of the chronic care model.
Latest:
Sustainable Lifelines: Supporting Integrated Behavioral Health Services for Children and Adolescents in the Accountable Care EraA reimbursement strategy for collaborative care models is presented to enhance access to integrated behavioral healthcare for children and adolescents from underserved areas.
Latest:
Bending the Curve Through Health Reform ImplementationAuthors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.
Latest:
Addressing Oncologists' Gaps in the Use of Biosimilar ProductsThe availability of biosimilar products may improve access to healthcare by increasing the number of therapeutic options available at potentially lower costs. As of April 2019, 18 such biological products had been approved by the FDA, including 4 biosimilars for trastuzumab, 3 each for infliximab and adalimumab, 2 each for pegfilgrastim and filgrastim, and 1 each for rituximab, epoetin alfa, bevacizumab, and etanercept. The pace of approvals has accelerated, from the first indication for a filgrastim biosimilar in 2015 to 3 approvals in 2016, 5 in 2017, and 9 through early 2019, 7 of which were announced in the 2018 calendar year.
Latest:
Predictors of Physician Use of Inpatient Electronic Health RecordsHospital and physician-hospital alignment, but not loyalty, are predictors of integrated electronic health record adoption by admitting physicians in an integrated system.
Latest:
IT-Enabled Systems Engineering Approach to Monitoring and Reducing ADEsSelf-empowering team resource management, when aided by information technology, appears to help reduce adverse drug events in primary care offices.
Latest:
Continuous Quality Improvement Program, Based on Lean Concepts, Allows Emptying of Emergency Department CorridorsA continuous quality improvement program, based on Lean concepts and including architectural, managerial, and organizational features, allows the emptying of emergency department corridors and the improvement of time interval measurements/quality indicators.
Latest:
A Systematic Review of Value-Based Insurance Design in Chronic DiseasesValue-based insurance design for prescription drug coverage increases drug adherence in patients with chronic disease, though their effect on clinical outcomes and health spending remain uncertain.
Latest:
Hospitalized Patients' and Family Members' Preferences for Real-Time, Transparent Access to Their Hospital RecordsThis mixed-methods study evaluated hospitalized patients’ and family members’ perceived communications mismatches and their calls for transparent real-time information and potential 21st-century solutions.
Latest:
Using Administrative Claims to Identify Children With Chronic Conditions in a Statewide Immunization RegistryThis study examines the feasibility and utility of using administrative claims from commercial health plans to identify children with chronic conditions in a statewide registry.
